NGNE

NASDAQ · Equity

Neurogene Inc

US Healthcare Biotechnology

Latest week
29 May 2026
Close
28.340000
Fair value
24.662622
Expectation
Negative 41.74%
Weekly Close Trend Line Fair Value Activity Lines

Chart Summary

Key Points

Week Ending
29 May 2026
Latest Close
28.34
12-Week Change
31.75%
Trend Signal
Active
Expectation
Negative 41.74%
Signal Weeks
3 of 12
Vs Trend Line
Above
Vs Fair Value
Above
Relative Strength
5.34
Market Dynamics
1.04

Over the latest 12 completed weeks ending 2026-05-29, NGNE rose 31.75%, moving from 21.51 to 28.34. The latest weekly close is above the Trend Line and above Fair Value. Trend Signal is active on the latest week and was active in 3 of the last 12 weeks. Relative Strength is 5.34 and has improved across the 12-week window. Market Dynamics is 1.04 on the latest week. Expectation is negative at 41.74%.